Literature DB >> 26151056

Carotenoids and non-alcoholic fatty liver disease.

Bahiddin Yilmaz1, Kazim Sahin1, Hande Bilen1, Ibrahim H Bahcecioglu1, Birdal Bilir1, Sara Ashraf1, Karim J Halazun1, Omer Kucuk1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a growing health problem around the world, especially in developed countries. NAFLD includes all cases of fatty liver disease from simple steatosis to cirrhosis, without excessive alcohol intake, use of steatogenic medication or hereditary disorders. Pathogenesis is associated with dietary high fat intake, decreased free fatty acid (FFA) oxidation, increased hepatic lipogenesis and lipolysis from the adipose tissue. These metabolic alterations contribute to the hepatic fat accumulation. Consequently, stimulated oxidative stress and inflammation play a major role in hepatocellular damage. Therefore, antioxidant and anti-inflammatory agents may have a role in the prevention of this disease. Carotenoids are potent antioxidant and anti-inflammatory micronutrients, which have been investigated in the prevention and treatment of NAFLD. The main sources of the carotenoids are fruits and vegetables. In this article we review the potential role and possible molecular mechanism of carotenoids in NAFLD.

Entities:  

Keywords:  Fatty liver; antioxidant; carotenoid; non-alcoholic steatohepatitis; oxidative stress; steatosis

Year:  2015        PMID: 26151056      PMCID: PMC4465602          DOI: 10.3978/j.issn.2304-3881.2015.01.11

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  93 in total

Review 1.  Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.

Authors:  J Aubert; K Begriche; L Knockaert; M A Robin; B Fromenty
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-06-12       Impact factor: 2.947

2.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 3.  From the metabolic syndrome to NAFLD or vice versa?

Authors:  Ester Vanni; Elisabetta Bugianesi; Anna Kotronen; Samuele De Minicis; Hannele Yki-Järvinen; Gianluca Svegliati-Baroni
Journal:  Dig Liver Dis       Date:  2010-03-06       Impact factor: 4.088

4.  Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

Authors:  Jörn M Schattenberg; Yongjun Wang; Rajat Singh; Raina M Rigoli; Mark J Czaja
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

5.  Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.

Authors:  John Willy Haukeland; Jan Kristian Damås; Zbigniew Konopski; Else Marit Løberg; Terese Haaland; Ingeborg Goverud; Peter A Torjesen; Kåre Birkeland; Kristian Bjøro; Pål Aukrust
Journal:  J Hepatol       Date:  2006-03-20       Impact factor: 25.083

Review 6.  Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

7.  Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet.

Authors:  Ibrahim Halil Bahcecioglu; Nalan Kuzu; Kerem Metin; Ibrahim Hanifi Ozercan; Bilal Ustündag; Kazim Sahin; Omer Kucuk
Journal:  Vet Med Int       Date:  2010-10-03

8.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1).

Authors:  G Ekström; M Ingelman-Sundberg
Journal:  Biochem Pharmacol       Date:  1989-04-15       Impact factor: 5.858

Review 10.  Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

Authors:  Min-Hsiung Pan; Ching-Shu Lai; Mei-Ling Tsai; Chi-Tang Ho
Journal:  Mol Nutr Food Res       Date:  2013-12-03       Impact factor: 5.914

View more
  17 in total

1.  Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.

Authors:  Azza S M Awad; Ekram N Abd Al Haleem; Wesam M El-Bakly; Mohie A Sherief
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-12       Impact factor: 3.000

2.  Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study.

Authors:  Mian-Li Xiao; Geng-Dong Chen; Fang-Fang Zeng; Rui Qiu; Wen-Qi Shi; Jie-Sheng Lin; Yi Cao; Hua-Bin Li; Wen-Hua Ling; Yu-Ming Chen
Journal:  Eur J Nutr       Date:  2018-03-29       Impact factor: 5.614

3.  Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose study.

Authors:  Zahra Bahadoran; Parvin Mirmiran; Zhaleh Tahmasebinejad; Fereidoun Azizi
Journal:  Nutr Metab (Lond)       Date:  2016-03-15       Impact factor: 4.169

Review 4.  The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Ana Gabriela Murillo; Diana M DiMarco; Maria Luz Fernandez
Journal:  Biology (Basel)       Date:  2016-11-08

5.  Association between Dietary Intakes of Nitrate and Nitrite and the Risk of Hypertension and Chronic Kidney Disease: Tehran Lipid and Glucose Study.

Authors:  Zahra Bahadoran; Parvin Mirmiran; Asghar Ghasemi; Mattias Carlström; Fereidoun Azizi; Farzad Hadaegh
Journal:  Nutrients       Date:  2016-12-21       Impact factor: 5.717

6.  A Prospective Study of Different Types of Dietary Fiber and Risk of Cardiovascular Disease: Tehran Lipid and Glucose Study.

Authors:  Parvin Mirmiran; Zahra Bahadoran; Sajad Khalili Moghadam; Azita Zadeh Vakili; Fereidoun Azizi
Journal:  Nutrients       Date:  2016-11-07       Impact factor: 5.717

7.  Total antioxidant capacity of the diet modulates the association between habitual nitrate intake and cardiovascular events: A longitudinal follow-up in Tehran Lipid and Glucose Study.

Authors:  Zahra Bahadoran; Mattias Carlström; Asghar Ghasemi; Parvin Mirmiran; Fereidoun Azizi; Farzad Hadaegh
Journal:  Nutr Metab (Lond)       Date:  2018-02-27       Impact factor: 4.169

Review 8.  Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.

Authors:  Hironori Kitade; Guanliang Chen; Yinhua Ni; Tsuguhito Ota
Journal:  Nutrients       Date:  2017-04-14       Impact factor: 5.717

9.  Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population.

Authors:  Zahra Ghasemzadeh; Hengameh Abdi; Samaneh Asgari; Maryam Tohidi; Davood Khalili; Majid Valizadeh; Siamak Moeini; Vahid Eidkhani; Fereidoun Azizi; Farzad Hadaegh
Journal:  Nutr Metab (Lond)       Date:  2016-06-24       Impact factor: 4.169

Review 10.  Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.

Authors:  Yinhua Ni; Fen Zhuge; Mayumi Nagashimada; Tsuguhito Ota
Journal:  Nutrients       Date:  2016-06-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.